Literature DB >> 9716185

Taxanes propagate apoptosis via two cell populations with distinctive cytological and molecular traits.

P J Moos1, F A Fitzpatrick.   

Abstract

Taxol and Taxotere propagate apoptosis in Jurkat T cells via molecular signals that coincide with the appearance of two distinct cell populations. Cell cycle arrest in G2-M phase and activation of cell cycle-dependent kinases begin within 2 h and extend to most cells by 16 h. Phosphorylation of Bcl-2 also begins within 2 h and intensifies from 2-16 h. Cell cycle arrest, activation of mitotic kinases, and phosphorylation of Bcl-2 coincided with the appearance of a population of metastable cells that accumulate YO-PRO-1 dye, are resistant to the caspase inhibitor carbobenzoxy-L-aspartyl-alpha-[(2,6-dichlorobenzoyl)oxy]methane, and have intact genomic DNA. Phosphorylation and deactivation of kinases that relay survival/mitogenesis signals in T cells begin after 8 h and are prominent by 12-16 h. Deactivated kinases include c-Raf-1, p44 extracellular receptor kinase, and the tyrosine kinases c-Lck and ZAP-70. Activation of Mr 40,000 and Mr 52,000 kinases is also prominent by 12-16 h. The modulation of all these kinases coincided with the activation of caspase-3 at 12 h and the appearance of a population of apoptotic cells that accumulate YO-PRO-1, are susceptible to the caspase inhibitor carbobenzoxy-L-aspartyl-alpha-[(2,6-dichloro-benzoyl)oxy]methane, and contain fragmented genomic DNA. This distinctive apoptosis signaling pathway may help account for the superior cytotoxic efficacy of taxanes in certain types of cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9716185

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  14 in total

1.  Phase I clinical trial of weekly docetaxel and exisulind, a novel inducer of apoptosis.

Authors:  Agustin A Garcia; Syma Iqbal; David Quinn; Susan Edwards; Heinz Josef Lenz; Jeff Weber
Journal:  Invest New Drugs       Date:  2006-01       Impact factor: 3.850

2.  Characterization and interlaboratory comparison of a gene expression signature for differentiating genotoxic mechanisms.

Authors:  Heidrun Ellinger-Ziegelbauer; Jennifer M Fostel; Chinami Aruga; Daniel Bauer; Eric Boitier; Shibing Deng; Donna Dickinson; Anne-Celine Le Fevre; Albert J Fornace; Olivier Grenet; Yizhong Gu; Jean-Christophe Hoflack; Masako Shiiyama; Roger Smith; Ronald D Snyder; Catherine Spire; Gotaro Tanaka; Jiri Aubrecht
Journal:  Toxicol Sci       Date:  2009-05-22       Impact factor: 4.849

3.  The X-linked inhibitor of apoptosis protein inhibits taxol-induced apoptosis in LNCaP cells.

Authors:  Takeo Nomura; Hiromitsu Mimata; Yusuke Takeuchi; Hideyuki Yamamoto; Eishichi Miyamoto; Yoshio Nomura
Journal:  Urol Res       Date:  2003-02-12

4.  Inactivation of wild-type p53 tumor suppressor by electrophilic prostaglandins.

Authors:  P J Moos; K Edes; F A Fitzpatrick
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

5.  Kinetics of hallmark biochemical changes in paclitaxel-induced apoptosis.

Authors:  J L Au; R R Kumar; D Li; M G Wientjes
Journal:  AAPS PharmSci       Date:  1999

6.  Pharmacodynamics of telomerase inhibition and telomere shortening by noncytotoxic suramin.

Authors:  Yuebo Gan; Jie Lu; Bertrand Z Yeung; Christopher T Cottage; M Guillaume Wientjes; Jessie L-S Au
Journal:  AAPS J       Date:  2014-11-26       Impact factor: 4.009

7.  Inhibition of HER-2 by three independent targeting strategies increases paclitaxel resistance of SKOV-3 ovarian carcinoma cells.

Authors:  Shaker Abuharbeid; Jürgen Apel; Gerhard Zugmaier; Cornelius Knabbe; Martin Sander; Sandra Gilbert; Frank Czubayko; Achim Aigner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-02-08       Impact factor: 3.000

8.  Combined-modality radioimmunotherapy: synergistic effect of paclitaxel and additive effect of bevacizumab.

Authors:  Beom-Su Jang; Sang-Myung Lee; Hyung Sub Kim; In Soo Shin; Faezeh Razjouyan; Shutao Wang; Zhengsheng Yao; Ira Pastan; Matthew R Dreher; Chang H Paik
Journal:  Nucl Med Biol       Date:  2011-12-14       Impact factor: 2.408

9.  Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells.

Authors:  Jason A Sprowl; Kerry Reed; Stephen R Armstrong; Carita Lanner; Baoqing Guo; Irina Kalatskaya; Lincoln Stein; Stacey L Hembruff; Adam Tam; Amadeo M Parissenti
Journal:  Breast Cancer Res       Date:  2012-01-06       Impact factor: 6.466

10.  Disruption of microtubule function in cultured human cells by a cytotoxic ruthenium(ii) polypyridyl complex.

Authors:  Nagham Alatrash; Faiza H Issa; Nada S Bawazir; Savannah J West; Kathleen E Van Manen-Brush; Charles P Shelor; Adam S Dayoub; Kenneth A Myers; Christopher Janetopoulos; Edwin A Lewis; Frederick M MacDonnell
Journal:  Chem Sci       Date:  2019-11-18       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.